Asked by: Preet Kaur Gill (Labour (Co-op) - Birmingham, Edgbaston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the budget is for the Smile for Life programme, and if she will publish a breakdown of costs.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
To improve prevention for our youngest children, we will roll out support education targeting one to three year olds in the new Smile for Life programme. We will work closely with local areas to ensure our national advice and educational materials are tailored appropriately for nurseries and other early years settings.
The Dentistry Recovery Plan is fully funded with £200 million, and will deliver new initiatives to address the challenges facing National Health Service dentistry, including an additional 2.5 million appointments.
Overall NHS spending totals will be set at budget in the usual way. We are committed to protecting funding for dentistry purposes and will ringfence dental funding in 2024/25. We will issue guidance to integrated care boards shortly, through NHS England’s 2024/25 revenue finance and contracting guidance.
Asked by: Karin Smyth (Labour - Bristol South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment has she made of the adequacy of the progress towards full delegated commissioning for Integrated Care Boards by April 2025 in (a) the South West, (b) the South East, (c) London and (d) the North East.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
The total spend on commissioning specialised services was £22.7 billion in 2022/23 and £25 billion in 2023/24. As formal delegation of specialised services to integrated care boards (ICBs) begins from 1 April 2024, all spend on commissioning these services in previous years has been the responsibility of NHS England, and not the ICBs. For 2024/25, NHS England is delegating £5.3 billion of commissioning resource to ICBs in the three regions, where delegation will begin from April 2024. This figure excludes high-cost drugs and devices spend.
The nine joint committee arrangements arose from a robust process, which included a readiness assessment, the Pre-Delegation Assessment Framework, made between the ICBs and NHS England regional teams, followed by a National Moderation Panel, and final decision taken by the NHS England Board. The NHS England Board papers for February 2023, December 2023, and March 2024 are available, respectively, at the following links:
The process concluded that a transitional year of joint commissioning would offer the most secure and stable transition towards delegation. There is a comprehensive programme structure in place to support the ICBs in the four regions that are working towards delegation in April 2025, to support them in being ready to take on the responsibilities. NHS England is continuing to work alongside ICBs to ensure that delegation agreements are in place, including ensuring appropriate collaborative arrangements are developed to support ICB commissioning of specialised services. These arrangements will be monitored by NHS England through its assurance processes for specialised services.
A webinar series for commissioning staff, including colleagues in ICBs, was delivered in 2023 across different aspects of specialised services, and there are additional webinars planned in 2024. There has been, and will continue to be, local engagement between regional commissioning teams and ICB teams, as the future operating model is co-developed. A suite of support materials has been shared with teams and continues to be updated. As examples, these include: Commissioning Change Management Business Rules; Finance and Accounting Standard Operating Procedure; and the Contracting Standard Operating Procedure.
NHS England develops services specification and clinical policies through its Clinical Reference Groups. There are 250 published service specifications which include clinical pathway, quality, and other relevant standards, which are specific to the clinical service. Regional commissioning teams, overseen by the statutory joint committees, are responsible for implementing the specifications in their commissioning of services, along with assessing compliance against national standards. NHS England has developed Specialised Services Quality Dashboards alongside service specifications, which provide additional data to monitor the quality of services.
Asked by: Karin Smyth (Labour - Bristol South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what (a) training and (b) support on specialised services is provided for staff working in integrated care boards in the (i) East of England, (ii) Midlands and (iii) North West following full delegation of commissioning in 2024-25.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
The total spend on commissioning specialised services was £22.7 billion in 2022/23 and £25 billion in 2023/24. As formal delegation of specialised services to integrated care boards (ICBs) begins from 1 April 2024, all spend on commissioning these services in previous years has been the responsibility of NHS England, and not the ICBs. For 2024/25, NHS England is delegating £5.3 billion of commissioning resource to ICBs in the three regions, where delegation will begin from April 2024. This figure excludes high-cost drugs and devices spend.
The nine joint committee arrangements arose from a robust process, which included a readiness assessment, the Pre-Delegation Assessment Framework, made between the ICBs and NHS England regional teams, followed by a National Moderation Panel, and final decision taken by the NHS England Board. The NHS England Board papers for February 2023, December 2023, and March 2024 are available, respectively, at the following links:
The process concluded that a transitional year of joint commissioning would offer the most secure and stable transition towards delegation. There is a comprehensive programme structure in place to support the ICBs in the four regions that are working towards delegation in April 2025, to support them in being ready to take on the responsibilities. NHS England is continuing to work alongside ICBs to ensure that delegation agreements are in place, including ensuring appropriate collaborative arrangements are developed to support ICB commissioning of specialised services. These arrangements will be monitored by NHS England through its assurance processes for specialised services.
A webinar series for commissioning staff, including colleagues in ICBs, was delivered in 2023 across different aspects of specialised services, and there are additional webinars planned in 2024. There has been, and will continue to be, local engagement between regional commissioning teams and ICB teams, as the future operating model is co-developed. A suite of support materials has been shared with teams and continues to be updated. As examples, these include: Commissioning Change Management Business Rules; Finance and Accounting Standard Operating Procedure; and the Contracting Standard Operating Procedure.
NHS England develops services specification and clinical policies through its Clinical Reference Groups. There are 250 published service specifications which include clinical pathway, quality, and other relevant standards, which are specific to the clinical service. Regional commissioning teams, overseen by the statutory joint committees, are responsible for implementing the specifications in their commissioning of services, along with assessing compliance against national standards. NHS England has developed Specialised Services Quality Dashboards alongside service specifications, which provide additional data to monitor the quality of services.
Asked by: Karin Smyth (Labour - Bristol South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate she has made of the proportion of specialised services that met national standards in the (a) 2022-23 and (b) 2023-24 financial years.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
The total spend on commissioning specialised services was £22.7 billion in 2022/23 and £25 billion in 2023/24. As formal delegation of specialised services to integrated care boards (ICBs) begins from 1 April 2024, all spend on commissioning these services in previous years has been the responsibility of NHS England, and not the ICBs. For 2024/25, NHS England is delegating £5.3 billion of commissioning resource to ICBs in the three regions, where delegation will begin from April 2024. This figure excludes high-cost drugs and devices spend.
The nine joint committee arrangements arose from a robust process, which included a readiness assessment, the Pre-Delegation Assessment Framework, made between the ICBs and NHS England regional teams, followed by a National Moderation Panel, and final decision taken by the NHS England Board. The NHS England Board papers for February 2023, December 2023, and March 2024 are available, respectively, at the following links:
The process concluded that a transitional year of joint commissioning would offer the most secure and stable transition towards delegation. There is a comprehensive programme structure in place to support the ICBs in the four regions that are working towards delegation in April 2025, to support them in being ready to take on the responsibilities. NHS England is continuing to work alongside ICBs to ensure that delegation agreements are in place, including ensuring appropriate collaborative arrangements are developed to support ICB commissioning of specialised services. These arrangements will be monitored by NHS England through its assurance processes for specialised services.
A webinar series for commissioning staff, including colleagues in ICBs, was delivered in 2023 across different aspects of specialised services, and there are additional webinars planned in 2024. There has been, and will continue to be, local engagement between regional commissioning teams and ICB teams, as the future operating model is co-developed. A suite of support materials has been shared with teams and continues to be updated. As examples, these include: Commissioning Change Management Business Rules; Finance and Accounting Standard Operating Procedure; and the Contracting Standard Operating Procedure.
NHS England develops services specification and clinical policies through its Clinical Reference Groups. There are 250 published service specifications which include clinical pathway, quality, and other relevant standards, which are specific to the clinical service. Regional commissioning teams, overseen by the statutory joint committees, are responsible for implementing the specifications in their commissioning of services, along with assessing compliance against national standards. NHS England has developed Specialised Services Quality Dashboards alongside service specifications, which provide additional data to monitor the quality of services.
Asked by: Nick Smith (Labour - Blaenau Gwent)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the NAO report Investigation into supply chain finance in the NHS, HC 734, published on 29 October 2021, what the costs have been to NHS Trusts which used the Earnd of switching to alternative salary advancement initiatives.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
As detailed in the National Audit Office (NAO) report, of the seven National Health Service trusts reported on by the NAO as having used the EARND scheme, two were reported as having lost money totalling £21,429. NHS England was not aware of any other NHS trusts losing money through the EARND scheme.
The identities of the seven NHS trusts were anonymised in the NAO report and therefore it is not possible to provide information on the costs to these trusts of using alternative salary advance schemes since the date of the report.
Sep. 13 2010
Source Page: Letter [not dated] from Bruce Keogh, NHS Medical Director, to Strategic Health Authorities regarding interim cancer drugs funding. 4 p.Found: Letter [not dated] from Bruce Keogh, NHS Medical Director, to Strategic Health Authorities regarding
Mentions:
1: Nigel Huddleston (Con - Mid Worcestershire) The Finance (No. 2) Bill builds on these improvements by seeking to reward work, boosting the housing - Speech Link
2: James Murray (LAB - Ealing North) They made that very clear in last month’s Budget, from which this Finance Bill arose. - Speech Link
3: Nigel Huddleston (Con - Mid Worcestershire) Total spending on the NHS is over £160 billion, and welfare spending is over £260 billion, massively - Speech Link
4: Richard Fuller (Con - North East Bedfordshire) Did he disagree with the increase in funding for the NHS? - Speech Link
5: Sarah Olney (LD - Richmond Park) For example, they have shown no interest in investing in the NHS. - Speech Link
Mar. 21 2011
Source Page: Table showing The Department of Health's business management system contracts database held information on contracts. 5 p.Found: LTDPN2010216[Information redacted in line with Section 40 of the FOIA] - National Project Manager - NHS
May. 13 2024
Source Page: Letter dated 08/05/2024 from Andrew Murrison MP to Maria Eagle MP regarding a written question concerning individuals in the MOD who earn more than £100,000 a year, includes breakdown by grade and job family. 2p.Found: , Data and Technology SCS1: Deputy Director 9 13 SCS2: Director 3 SCS3: Director General 1 Finance